Nelarabine in combination with intensive modified BFM AALL00P2: A pilot study for the treatment of high risk T-ALL a report from the Children's Oncology Group

被引：0
|
作者：
Dunsmore, K. [1 ]
Devidas, M. [1 ]
Borowitz, M. J. [1 ]
Winick, N. [1 ]
Hunger, S. P. [1 ]
Carroll, W. L. [1 ]
Camitta, B. M. [1 ]
机构：
[1] Childrens Oncol Grp, Arcadia, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.10002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10002
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Winter, Stuart S.
    Devidas, Meenakshi
    Wood, Brent
    Borowitz, Michael J.
    Loh, Mignon L.
    Asselin, Barbara
    Murphy, John
    Raetz, Elizabeth
    Winick, Naomi
    Hunger, Stephen
    Carroll, William
    Dunsmore, Kimberly
    BLOOD, 2010, 116 (21) : 378 - 378
  • [32] Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-Cell malignancies: A report from the children's oncology group
    Berg, SL
    Blaney, SM
    Devidas, M
    Lampkin, TA
    Murgo, A
    Bernstein, M
    Billett, A
    Kurtzberg, J
    Reaman, G
    Gaynon, P
    Whitlock, J
    Krailo, M
    Harris, MB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3376 - 3382
  • [33] A pilot induction regimen incorporating dinutuximab and sargramostim for the treatment of newly diagnosed high-risk neuroblastoma: A report from the Children's Oncology Group.
    Federico, Sara Michele
    Naranjo, Arlene
    Zhang, Fan
    Marachelian, Araz
    Desai, Ami Vijay
    Shimada, Hiroyuki
    Braunstein, Steve E.
    Tinkle, Christopher L.
    Yanik, Gregory A.
    Asgharzadeh, Shahab
    Sondel, Paul M.
    Yu, Alice L.
    Acord, Michael
    Parisi, Marguerite T.
    Shulkin, Barry L.
    DuBois, Steven G.
    Bagatell, Rochelle
    Park, Julie R.
    Furman, Wayne Lee
    Shusterman, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [34] Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and BLymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731
    Li, Amanda M.
    Rabin, Karen R.
    Kairalla, John
    Wang, Cindy
    Devidas, Meenakshi
    Militano, Olga
    Okada, Maki
    Hitzler, Johann K.
    Angiolillo, Anne L.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Gupta, Sumit
    Rau, Rachel E.
    BLOOD, 2021, 138
  • [35] Treatment-Related Mortality (TRM) in Children with Down Syndrome (DS) and B-Lymphoblastic Leukemia (B-ALL): An Interim Report from the Children's Oncology Group Trials AALL0932 and AALL1131
    Rabin, Karen R.
    Hitzler, Johann
    Rodriguez, Vilmarie
    Schore, Reuven
    Angiolillo, Anne
    Burke, Michael J.
    Salzer, Wanda
    Maloney, Kelly
    Lu, Xiaomin
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth
    Hunger, Stephen P.
    BLOOD, 2015, 126 (23)
  • [36] Capizzi-Style Methotrexate with Pegasparagase (C-MTX) Is Superior to High-Dose Methotrexate (HDMTX) in T-Lineage Acute Lymphoblastic Leukemia (T-ALL): Results from Children's Oncology Group (COG) AALL0434
    Winter, Stuart S.
    Devidas, Meenakshi
    Chen, Si
    Asselin, Barbara
    Carroll, William L.
    Wood, Brent L.
    Esiashvili, Natia
    Nikki, Briegel J.
    Hayashi, Robert J.
    Loh, Mignon L.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Raetz, Elizabeth
    Winick, Naomi J.
    Hunger, Stephen P.
    Dunsmore, Kimberly P.
    BLOOD, 2015, 126 (23)
  • [37] Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group
    Reshmi, Shalini C.
    Harvey, Richard C.
    Roberts, Kathryn G.
    Stonerock, Eileen
    Smith, Amy
    Jenkins, Heather
    Chen, I-Ming
    Valentine, Marc
    Liu, Yu
    Li, Yongjin
    Shao, Ying
    Easton, John
    Payne-Turner, Debbie
    Gu, Zhaohui
    Thai Hoa Tran
    Nguyen, Jonathan V.
    Devidas, Meenakshi
    Dai, Yunfeng
    Heerema, Nyla A.
    Carroll, Andrew J., III
    Raetz, Elizabeth A.
    Borowitz, Michael J.
    Wood, Brent L.
    Angiolillo, Anne L.
    Burke, Michael J.
    Salzer, Wanda L.
    Zweidler-McKay, Patrick A.
    Rabin, Karen R.
    Carroll, William L.
    Zhang, Jinghui
    Loh, Mignon L.
    Mullighan, Charles G.
    Willman, Cheryl L.
    Gastier-Foster, Julie M.
    Hunger, Stephen P.
    BLOOD, 2017, 129 (25) : 3352 - 3361
  • [38] TREATMENT Toxicity in Adolescents and Young ADULT (AYA) PATIENTS COMPARED with Younger PATIENTS TREATED for HIGH RISK B-Precursor ACUTE LYMPHOBLASTIC LEUKEMIA (HR-ALL): A REPORT From the CHILDREN'S Oncology GROUP STUDY AALL0232
    Larsen, Eric C.
    Salzer, Wanda
    Nachman, James
    Devidas, Meenakshi
    Freyer, David R.
    Raetz, Elizabeth A.
    Winick, Naomi
    Hunger, Stephen P.
    Carroll, William L.
    BLOOD, 2011, 118 (21) : 655 - 655
  • [39] Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232
    Larsen, Eric C.
    Devidas, Meenakshi
    Chen, Si
    Salzer, Wanda L.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Mattano, Leonard A., Jr.
    Cole, Catherine
    Eicher, Alisa
    Haugan, Maureen
    Sorenson, Mark
    Heerema, Nyla A.
    Carroll, Andrew A.
    Gastier-Foster, Julie M.
    Borowitz, Michael J.
    Wood, Brent L.
    Willman, Cheryl L.
    Winick, Naomi J.
    Hunger, Stephen P.
    Carroll, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (20) : 2380 - U129
  • [40] Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031
    Schultz, K. R.
    Devidas, M.
    Bowman, W. P.
    Aledo, A.
    Slayton, W. B.
    Sather, H.
    Zheng, H. W.
    Davies, S. M.
    Gaynon, P. S.
    Trigg, M.
    Rutledge, R.
    Jorstad, D.
    Carroll, A. J.
    Heerema, N.
    Winick, N.
    Borowitz, M. J.
    Hunger, S. P.
    Carroll, W. L.
    Camitta, B.
    LEUKEMIA, 2014, 28 (04) : 964 - 967
12345